Forsta AP Fonden Invests $24.43 Million in Marsh & McLennan Companies, Inc. $MRSH

Forsta AP Fonden acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 131,700 shares of the financial services provider’s stock, valued at approximately $24,433,000.

A number of other institutional investors also recently made changes to their positions in MRSH. Numerai GP LLC boosted its stake in shares of Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after buying an additional 33,729 shares during the period. Swiss Life Asset Management Ltd boosted its stake in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares during the period. Rockland Trust Co. boosted its stake in shares of Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after buying an additional 10,734 shares during the period. Barclays PLC boosted its stake in shares of Marsh & McLennan Companies by 41.7% in the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after buying an additional 647,987 shares during the period. Finally, Bridges Investment Management Inc. boosted its stake in shares of Marsh & McLennan Companies by 4.4% in the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock valued at $15,356,000 after buying an additional 3,177 shares during the period. Institutional investors own 87.99% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on MRSH. Piper Sandler cut their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Wells Fargo & Company lowered their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research report on Thursday, April 9th. Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Cantor Fitzgerald boosted their price objective on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Finally, Bank of America lowered their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $203.56.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.38% of the stock is owned by insiders.

Marsh & McLennan Companies Stock Up 0.1%

Shares of NYSE:MRSH opened at $159.73 on Friday. The company has a fifty day moving average of $164.87 and a 200-day moving average of $172.02. The company has a market capitalization of $77.17 billion, a PE ratio of 19.97, a price-to-earnings-growth ratio of 2.33 and a beta of 0.65. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52-week low of $157.74 and a 52-week high of $235.78.

Marsh & McLennan Companies (NYSE:MRSH) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company’s revenue was up 7.6% compared to the same quarter last year. On average, equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.